Protagenic Therapeutics, Inc. (PTIX)
0.4174
0.00 (0.00%)
USD |
OTCM |
Nov 19, 16:00
Protagenic Therapeutics Cash from Operations (Quarterly) : -0.4889M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.4889M |
| June 30, 2026 | -0.9443M |
| March 31, 2026 | 0.2655M |
| December 31, 2025 | -0.5097M |
| September 30, 2025 | -1.395M |
| June 30, 2025 | -1.751M |
| March 31, 2025 | -1.068M |
| December 31, 2024 | -0.8198M |
| September 30, 2024 | -0.1857M |
| June 30, 2024 | -1.552M |
| March 31, 2024 | -1.659M |
| December 31, 2023 | -1.144M |
| September 30, 2023 | -0.6558M |
| June 30, 2023 | -1.532M |
| March 31, 2023 | -0.3718M |
| December 31, 2022 | -0.1809M |
| September 30, 2022 | -0.5352M |
| June 30, 2022 | -0.8471M |
| March 31, 2022 | -0.4306M |
| December 31, 2021 | -0.4051M |
| September 30, 2021 | -1.075M |
| June 30, 2021 | -0.7104M |
| March 31, 2021 | -0.6077M |
| December 31, 2020 | -0.3209M |
| September 30, 2020 | -0.5178M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.1457M |
| March 31, 2020 | -0.3644M |
| December 31, 2019 | -0.1494M |
| September 30, 2019 | -0.0618M |
| June 30, 2019 | -0.0808M |
| March 31, 2019 | -0.196M |
| December 31, 2018 | -0.3078M |
| September 30, 2018 | -0.1596M |
| June 30, 2018 | -0.3448M |
| March 31, 2018 | -0.259M |
| December 31, 2017 | -0.417M |
| September 30, 2017 | -0.3588M |
| June 30, 2017 | -0.2469M |
| March 31, 2017 | -0.3574M |
| December 31, 2016 | -0.3418M |
| September 30, 2016 | -0.2961M |
| June 30, 2016 | -0.4451M |
| March 31, 2016 | -0.0574M |
| June 30, 2015 | -0.095M |
| March 31, 2015 | -0.092M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -6.754M |
| Sangamo Therapeutics, Inc. | -19.28M |
| Sarepta Therapeutics, Inc. | 59.97M |
| Anixa Biosciences, Inc. | -1.77M |
| Vicapsys Life Sciences, Inc. | -0.0051M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -1.681M |
| Free Cash Flow Per Share (Quarterly) | -0.2701 |
| Free Cash Flow to Equity (Quarterly) | -0.4889M |
| Free Cash Flow to Firm (Quarterly) | -0.4889M |
| Free Cash Flow Yield | -222.4% |